Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline for major depressive disorder
IRCT201502191556N74Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of citicoline in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Sep 2015; status: completed.
02
Drugs
citicoline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201502191556N74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201502191556N74.